Literature DB >> 1238134

Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra.

A Dray, L J Fowler, N R Oakley, M A Simmonds, T Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1238134      PMCID： PMC1666838     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

2.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

Authors:  H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

4.  Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo.

Authors:  L J Fowler; R A John
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857
  4 in total
  6 in total

1.  GABA-like properties of flurazepam and baclofen suggested by rotational behaviour following unilateral intranigral injection: a comparison with the GABA agonist muscimol [proceedings].

Authors:  J L Waddington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

2.  Rotational behaviour and cGMP responses following manipulation of nigral mechanisms with chlordiazepoxide. Evidence for enhancement of GABA transmission by benzodiazepines.

Authors:  J L Waddington; A Longden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

3.  The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].

Authors:  G Koob; M del Fiacco; S D Iversen
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

4.  Caudate stimulation and substantia nigra activity in the rat.

Authors:  A Dray; T J Gonye; N R Oakley
Journal:  J Physiol       Date:  1976-08       Impact factor: 5.182

5.  Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].

Authors:  A L Jaton; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines.

Authors:  Y Matsui; T Kamioka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.